40 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
be expected to result in a Material Adverse Effect. None of the Company’s or any Subsidiary’s employees is a member of a labor union that relates … . Department of State, the United Nations Security Council, the European Union, His Majesty’s Treasury or any other relevant sanctions authority
8-K
EX-1.1
COGT
Cogent Biosciences Inc
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
Security Council, the European Union, His Majesty’s Treasury or other relevant sanctions authority (collectively, “Sanctions”), or (B) located, organized … with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) (collectively, the “Privacy Laws”). To ensure compliance
424B5
749xm4c1f
8 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
73f3rr4
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
4iyaiu
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
8-K/A
EX-1.1
u2utzgcl1c91f
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
99mr9r xx1zf5a974
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm
424B5
13lc49us
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
ncq0 nh6b9c
13 Jun 22
Prospectus supplement for primary offering
6:11am
8-K
EX-10.1
8p74a8q2 2pp
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-1.1
3vskr0
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
424B5
0x4vuij
2 Dec 20
Prospectus supplement for primary offering
5:06pm